Over 150 research primates suffered a Shigella outbreak at a research center, but the resulting immunological data has provided crucial insights for vaccine development. Published in Science Translational Medicine, the study identified specific bacterial targets and precise antibody binding sites, representing a step toward rational Shigella vaccine design.
Background
Shigella causes over 200 million gastrointestinal infections and approximately 200,000 deaths annually worldwide, primarily affecting children in developing nations. No effective vaccine currently exists despite decades of research efforts.
- Source
- Ars Technica
- Published
- Sep 4, 2026 at 04:14 AM
- Score
- 7.0 / 10